CTA
TEVA icon

Chesley Taft & Associates’s Teva Pharmaceuticals TEVA Stock Holding History

Chesley Taft & Associates’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-22,287
Closed -$893K – 275
2013
Q4 		$893K Sell
22,287
-13,679
-38% -$539K 0.09% 168
2013
Q3 		$1.36M Sell
35,966
-9,900
-22% -$386K 0.15% 135
2013
Q2 		$1.8M Buy
+45,866
New +$1.79M 0.21% 111

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Chesley Taft & Associates's TEVA Position: Q1 2014 in Review

Chesley Taft & Associates sold out of Teva Pharmaceuticals (TEVA) in Q1 2014, closing a stake of 22,287 shares — an estimated $893K sold.

Chesley Taft & Associates first reported a position in TEVA in Q2 2013 and held it in 3 quarters. The position peaked at $1.8M in Q2 2013. 770 funds tracked by Wall St. Rank hold TEVA as of Q1 2014.

  • Chesley Taft & Associates reported no remaining Teva Pharmaceuticals position as of Q1 2014 after selling out during the quarter.
  • Chesley Taft & Associates sold 22,287 Teva Pharmaceuticals shares in Q1 2014, an estimated $893K.
  • Chesley Taft & Associates first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 3 quarters.
  • Chesley Taft & Associates's Teva Pharmaceuticals position peaked at $1.8M in Q2 2013.
  • 770 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2014.

Based on Chesley Taft & Associates's 13F filing for Q1 2014, filed 11 Apr 2014.